Options: Show MedDRA Preferred Terms
Information about indications was extracted from the indications and usage sections of the labels.
Indication | Labels | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Anaphylactic shock | x | x | x | x | x | x | x | |||
Angioedema | x | x | x | x | x | |||||
Cold urticaria | x | x | x | x | ||||||
Conjunctivitis | x | x | x | |||||||
Conjunctivitis allergic | x | x | x | x | ||||||
Hypersensitivity | x | x | x | x | x | x | x | |||
Rhinitis allergic | x | x | x | |||||||
Seasonal allergy | x | x | x | x | ||||||
Urticaria | x | x | x | x | x | x | x | |||
Urticaria physical | x | x | x | x | ||||||
Vasomotor rhinitis | x | x | x | x |
standard – alternative
100% | ||
75% | ||
50% | ||
10% | ||
frequent (1% to 100%) | ||
infrequent (0.1% to 1%) | ||
rare (<0.1%) | ||
postmarketing | ||
0% | ||
no frequency information | ||
not found on label |